The SPDR S&P Pharmaceuticals ETF (XPH) experienced unusually high trading volume on Friday, with over 318,000 shares traded compared to a three-month average of approximately 57,000. The ETF’s shares rose by 1.5% during the day.
Key components driving this volume included Pfizer, which gained about 1.6% with over 10.8 million shares traded, and Merck, up about 2% on more than 3.5 million shares. Omeros (OMER) led the gains at approximately 10.5%, while Pacira Biosciences saw a decline of around 0.9%.
